4

PRIMARY DOCUMENT

Company: Viridian Therapeutics, Inc.\DE
Filed: July 21, 2014
Period of Report: July 17, 2014
Accession Number: 0001382963-14-000039

View Document ↗ View on SEC.gov ↗